Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Growth hormone treatment for growth failure in pediatric patients with Crohn's disease.

Heyman MB, Garnett EA, Wojcicki J, Gupta N, Davis C, Cohen SA, Gold BD, Kirschner BS, Baldassano RN, Ferry GD, Winter HS, Kaplan S.

J Pediatr. 2008 Nov;153(5):651-8, 658.e1-3. doi: 10.1016/j.jpeds.2008.04.064. Epub 2008 Jun 27.

2.

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A, Vermeire S, Van de Mierop FJ, Coche JC, van der Woude J, Ochsenk├╝hn T, van Bodegraven AA, Van Hootegem PP, Lambrecht GL, Mana F, Rutgeerts P, Feagan BG, Hommes D; Belgian Inflammatory Bowel Disease Research Group.; North-Holland Gut Club..

Lancet. 2008 Feb 23;371(9613):660-7. doi: 10.1016/S0140-6736(08)60304-9.

PMID:
18295023
3.

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R; REACH Study Group..

Gastroenterology. 2007 Mar;132(3):863-73; quiz 1165-6. Epub 2006 Dec 3.

PMID:
17324398
4.

Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease.

Walters TD, Gilman AR, Griffiths AM.

Inflamm Bowel Dis. 2007 Apr;13(4):424-30.

PMID:
17206672
5.

A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis.

Tung J, Loftus EV Jr, Freese DK, El-Youssef M, Zinsmeister AR, Melton LJ 3rd, Harmsen WS, Sandborn WJ, Faubion WA Jr.

Inflamm Bowel Dis. 2006 Dec;12(12):1093-100.

PMID:
17119382
6.

Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial.

Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S.

Clin Gastroenterol Hepatol. 2006 Jun;4(6):744-53. Epub 2006 May 6.

PMID:
16682258
7.

Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children.

Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR.

Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13260-5. Epub 2005 Sep 6.

8.

Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis.

Han X, Sosnowska D, Bonkowski EL, Denson LA.

Gastroenterology. 2005 Jul;129(1):185-203.

PMID:
16012947
9.

Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study.

Calenda KA, Schornagel IL, Sadeghi-Nejad A, Grand RJ.

Inflamm Bowel Dis. 2005 May;11(5):435-41.

PMID:
15867582
10.

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.

Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.

Dig Liver Dis. 2004 May;36(5):342-7.

PMID:
15191204
11.

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease.

Su C, Lichtenstein GR, Krok K, Brensinger CM, Lewis JD.

Gastroenterology. 2004 May;126(5):1257-69. Review.

PMID:
15131785
12.

Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards.

BAYLEY N, PINNEAU SR.

J Pediatr. 1952 Apr;40(4):423-41. No abstract available.

PMID:
14918032
13.

Adult height in patients with early onset of Crohn's disease.

Sawczenko A, Ballinger AB, Croft NM, Sanderson IR, Savage MO.

Gut. 2003 Mar;52(3):454-5; author reply 455. No abstract available.

14.

The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease.

Otley A, Smith C, Nicholas D, Munk M, Avolio J, Sherman PM, Griffiths AM.

J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):557-63.

PMID:
12394384
15.

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.

Mauras N, George D, Evans J, Milov D, Abrams S, Rini A, Welch S, Haymond MW.

Metabolism. 2002 Jan;51(1):127-35.

PMID:
11782884
16.

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.

Markowitz J, Grancher K, Kohn N, Lesser M, Daum F.

Gastroenterology. 2000 Oct;119(4):895-902.

PMID:
11040176
17.

A preliminary study of growth hormone therapy for Crohn's disease.

Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ.

N Engl J Med. 2000 Jun 1;342(22):1633-7.

18.

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine.

D'Haens G, Geboes K, Rutgeerts P.

Gastrointest Endosc. 1999 Nov;50(5):667-71.

PMID:
10536324
19.

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

D'haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F, Braakman T, Schaible T, Geboes K, Rutgeerts P.

Gastroenterology. 1999 May;116(5):1029-34.

PMID:
10220494
20.

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.

D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P.

Gastroenterology. 1998 Feb;114(2):262-7.

PMID:
9453485

Supplemental Content

Support Center